NCT03301948

Brief Summary

Healthy male participants are recruited to observe potentially deleterious changes in appetite regulation and metabolic control. Participants will be provided with an energy intake representative of their daily requirements on the first day of one trial and will be provided with an additional 50% energy intake on the first day of another trial. Outcome variables will be assessed during the second day of each trial in response to a fixed mixed macronutrient meal tolerance test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 8, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 4, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 11, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 11, 2019

Completed
Last Updated

January 14, 2019

Status Verified

January 1, 2019

Enrollment Period

1.7 years

First QC Date

August 8, 2017

Last Update Submit

January 11, 2019

Conditions

Outcome Measures

Primary Outcomes (5)

  • Appetite perceptions assessed using 100mm visual analogue scales

    Appetite perceptions using 100mm visual analogue scales

    28 hours

  • Ad libitum energy intake

    Ad libitum energy intake using an ad libitum pasta meal

    28 hours

  • Plasma acylated ghrelin concentrations

    Measured using ELISA from venous blood samples

    28 hours

  • Plasma peptide YY concentrations

    Measured using ELISA from venous blood samples

    28 hours

  • Plasma GLP-1 concentrations

    Measured using ELISA from venous blood samples

    28 hours

Secondary Outcomes (5)

  • Palatability perceptions assessed using 100mm visual analogue scales

    28 hours

  • Blinding assessment

    One week

  • Plasma insulin concentrations

    28 hours

  • Plasma glucose concentrations

    28 hours

  • Plasma triglyceride concentrations

    28 hours

Study Arms (2)

Overfeed

EXPERIMENTAL

Experimental trial where participants are provided with 50% higher energy intake than their estimated requirements on the first day of the trial.

Other: Overfeed

Energy Balance

EXPERIMENTAL

Experimental trial where participants are provided with an energy intake equal to their estimated requirements on the first day of the trial.

Other: Energy Balance

Interventions

Participants consume energy intakes that are 50% higher than their estimated requirements instead of consuming energy intakes equal to their estimated requirements

Overfeed

Participants consume energy intakes equal to their estimated requirements instead of consuming intakes that are 50% higher than their estimated requirements

Energy Balance

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • weight stable
  • healthy

You may not qualify if:

  • any personal history of cardiovascular or metabolic disease
  • smokers
  • currently dieting
  • taking any medication known to influence appetite or metabolic outcomes
  • highly active (IPAQ category 3)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leeds Beckett University

Leeds, LS6 3QS, United Kingdom

Location

MeSH Terms

Conditions

Metabolic DiseasesAppetitive Behavior

Condition Hierarchy (Ancestors)

Nutritional and Metabolic DiseasesBehavior, AnimalBehavior

Study Officials

  • Kevin Deighton, PhD

    Leeds Beckett University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Single blind, counterbalanced, crossover trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2017

First Posted

October 4, 2017

Study Start

May 1, 2017

Primary Completion

January 11, 2019

Study Completion

January 11, 2019

Last Updated

January 14, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations